Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria

Research output: Contribution to journalReview article

Abstract

Chronic spontaneous urticaria (CSU) is defined by the appearance of wheals and a variable presence of angioedema which persists for at least 6 weeks. It represents the most common subtype of chronic urticaria and is gaining importance in civil society because of its association with impaired quality of life. Moreover, CSU has a growing impact on national health systems representing a great burden due to its variable rate of response to the approved therapies. In this scenario, the identification of clinical and molecular biomarkers is of pivotal importance. Some groups are trying to detect molecules which would be able to help clinicians in reaching a proper diagnosis; additionally, the opportunity to describe disease severity which leads to cluster patients in different groups could fill the gap in the numerous unmet clinical needs. Several biomarkers are currently being studied with the purpose to predict the response to a defined therapy; unfortunately, none of them are ready to be translated from bench to bedside.

Original languageEnglish
Number of pages1
JournalJournal of Immunology Research
Volume2018
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Urticaria
Biomarkers
Angioedema
Quality of Life
Health
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

@article{0e6ada84bc764262882d113f14f47e73,
title = "Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria",
abstract = "Chronic spontaneous urticaria (CSU) is defined by the appearance of wheals and a variable presence of angioedema which persists for at least 6 weeks. It represents the most common subtype of chronic urticaria and is gaining importance in civil society because of its association with impaired quality of life. Moreover, CSU has a growing impact on national health systems representing a great burden due to its variable rate of response to the approved therapies. In this scenario, the identification of clinical and molecular biomarkers is of pivotal importance. Some groups are trying to detect molecules which would be able to help clinicians in reaching a proper diagnosis; additionally, the opportunity to describe disease severity which leads to cluster patients in different groups could fill the gap in the numerous unmet clinical needs. Several biomarkers are currently being studied with the purpose to predict the response to a defined therapy; unfortunately, none of them are ready to be translated from bench to bedside.",
author = "Marco Folci and Enrico Heffler and Canonica, {Giorgio W.} and Raffaello Furlan and Enrico Brunetta",
year = "2018",
month = "1",
day = "1",
doi = "10.1155/2018/5615109",
language = "English",
volume = "2018",
journal = "Journal of Immunology Research",
issn = "2314-8861",
publisher = "Hindawi Limited",

}

TY - JOUR

T1 - Cutting Edge

T2 - Biomarkers for Chronic Spontaneous Urticaria

AU - Folci, Marco

AU - Heffler, Enrico

AU - Canonica, Giorgio W.

AU - Furlan, Raffaello

AU - Brunetta, Enrico

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Chronic spontaneous urticaria (CSU) is defined by the appearance of wheals and a variable presence of angioedema which persists for at least 6 weeks. It represents the most common subtype of chronic urticaria and is gaining importance in civil society because of its association with impaired quality of life. Moreover, CSU has a growing impact on national health systems representing a great burden due to its variable rate of response to the approved therapies. In this scenario, the identification of clinical and molecular biomarkers is of pivotal importance. Some groups are trying to detect molecules which would be able to help clinicians in reaching a proper diagnosis; additionally, the opportunity to describe disease severity which leads to cluster patients in different groups could fill the gap in the numerous unmet clinical needs. Several biomarkers are currently being studied with the purpose to predict the response to a defined therapy; unfortunately, none of them are ready to be translated from bench to bedside.

AB - Chronic spontaneous urticaria (CSU) is defined by the appearance of wheals and a variable presence of angioedema which persists for at least 6 weeks. It represents the most common subtype of chronic urticaria and is gaining importance in civil society because of its association with impaired quality of life. Moreover, CSU has a growing impact on national health systems representing a great burden due to its variable rate of response to the approved therapies. In this scenario, the identification of clinical and molecular biomarkers is of pivotal importance. Some groups are trying to detect molecules which would be able to help clinicians in reaching a proper diagnosis; additionally, the opportunity to describe disease severity which leads to cluster patients in different groups could fill the gap in the numerous unmet clinical needs. Several biomarkers are currently being studied with the purpose to predict the response to a defined therapy; unfortunately, none of them are ready to be translated from bench to bedside.

UR - http://www.scopus.com/inward/record.url?scp=85058921358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058921358&partnerID=8YFLogxK

U2 - 10.1155/2018/5615109

DO - 10.1155/2018/5615109

M3 - Review article

C2 - 30584542

AN - SCOPUS:85058921358

VL - 2018

JO - Journal of Immunology Research

JF - Journal of Immunology Research

SN - 2314-8861

ER -